Constitutively active CCK2 receptor splice variant increases Src-dependent HIF-1α expression and tumor growth

Celia Chao, E. Goluszko, Y. T. Lee, A. A. Kolokoltsov, R. A. Davey, T. Uchida, Courtney Townsend, Mark Hellmich

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Gastrointestinal (GI) cancers ectopically express multiple splice variants of the cholecystokinin-2 (CCK2)/gastrin receptor; however, their relative contributions to the cancer phenotype are unknown. The aim of this study was to compare the effects of CCK2 receptor (CCK2R) and CCK2i4svR expression on cell growth both in vitro and in vivo using a human epithelial cell model, HEK239. In vitro, receptor variant expression did not affect cell proliferation either in the absence or presence of agonist. However, in vivo, the expression of CCK2i4svR, but not CCK2R, increases HEK293 tumor growth in a constitutive, Src-dependent manner. Enhanced tumorigenicity of CCK2i4svR is associated with an Src-dependent increase in the transcription factor, hypoxia-inducible factor-1α, its downstream target, vascular endothelial growth factor and tumor micro-vessel density, suggesting that CCK2i4svR may contribute to the growth and spread of GI cancers through agonist-independent mechanisms that enhance tumor angiogenesis.

Original languageEnglish (US)
Pages (from-to)1013-1019
Number of pages7
JournalOncogene
Volume26
Issue number7
DOIs
StatePublished - Feb 15 2007

Fingerprint

Cholecystokinin B Receptor
Gastrointestinal Neoplasms
Growth
Neoplasms
Hypoxia-Inducible Factor 1
Vascular Endothelial Growth Factor A
Transcription Factors
Epithelial Cells
Cell Proliferation
Phenotype
In Vitro Techniques

Keywords

  • Gastrin receptor
  • Gastrointestinal cancer
  • Src kinase

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Constitutively active CCK2 receptor splice variant increases Src-dependent HIF-1α expression and tumor growth. / Chao, Celia; Goluszko, E.; Lee, Y. T.; Kolokoltsov, A. A.; Davey, R. A.; Uchida, T.; Townsend, Courtney; Hellmich, Mark.

In: Oncogene, Vol. 26, No. 7, 15.02.2007, p. 1013-1019.

Research output: Contribution to journalArticle

Chao, Celia ; Goluszko, E. ; Lee, Y. T. ; Kolokoltsov, A. A. ; Davey, R. A. ; Uchida, T. ; Townsend, Courtney ; Hellmich, Mark. / Constitutively active CCK2 receptor splice variant increases Src-dependent HIF-1α expression and tumor growth. In: Oncogene. 2007 ; Vol. 26, No. 7. pp. 1013-1019.
@article{1777a08b274d40fa97d8e772181c9985,
title = "Constitutively active CCK2 receptor splice variant increases Src-dependent HIF-1α expression and tumor growth",
abstract = "Gastrointestinal (GI) cancers ectopically express multiple splice variants of the cholecystokinin-2 (CCK2)/gastrin receptor; however, their relative contributions to the cancer phenotype are unknown. The aim of this study was to compare the effects of CCK2 receptor (CCK2R) and CCK2i4svR expression on cell growth both in vitro and in vivo using a human epithelial cell model, HEK239. In vitro, receptor variant expression did not affect cell proliferation either in the absence or presence of agonist. However, in vivo, the expression of CCK2i4svR, but not CCK2R, increases HEK293 tumor growth in a constitutive, Src-dependent manner. Enhanced tumorigenicity of CCK2i4svR is associated with an Src-dependent increase in the transcription factor, hypoxia-inducible factor-1α, its downstream target, vascular endothelial growth factor and tumor micro-vessel density, suggesting that CCK2i4svR may contribute to the growth and spread of GI cancers through agonist-independent mechanisms that enhance tumor angiogenesis.",
keywords = "Gastrin receptor, Gastrointestinal cancer, Src kinase",
author = "Celia Chao and E. Goluszko and Lee, {Y. T.} and Kolokoltsov, {A. A.} and Davey, {R. A.} and T. Uchida and Courtney Townsend and Mark Hellmich",
year = "2007",
month = "2",
day = "15",
doi = "10.1038/sj.onc.1209862",
language = "English (US)",
volume = "26",
pages = "1013--1019",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Constitutively active CCK2 receptor splice variant increases Src-dependent HIF-1α expression and tumor growth

AU - Chao, Celia

AU - Goluszko, E.

AU - Lee, Y. T.

AU - Kolokoltsov, A. A.

AU - Davey, R. A.

AU - Uchida, T.

AU - Townsend, Courtney

AU - Hellmich, Mark

PY - 2007/2/15

Y1 - 2007/2/15

N2 - Gastrointestinal (GI) cancers ectopically express multiple splice variants of the cholecystokinin-2 (CCK2)/gastrin receptor; however, their relative contributions to the cancer phenotype are unknown. The aim of this study was to compare the effects of CCK2 receptor (CCK2R) and CCK2i4svR expression on cell growth both in vitro and in vivo using a human epithelial cell model, HEK239. In vitro, receptor variant expression did not affect cell proliferation either in the absence or presence of agonist. However, in vivo, the expression of CCK2i4svR, but not CCK2R, increases HEK293 tumor growth in a constitutive, Src-dependent manner. Enhanced tumorigenicity of CCK2i4svR is associated with an Src-dependent increase in the transcription factor, hypoxia-inducible factor-1α, its downstream target, vascular endothelial growth factor and tumor micro-vessel density, suggesting that CCK2i4svR may contribute to the growth and spread of GI cancers through agonist-independent mechanisms that enhance tumor angiogenesis.

AB - Gastrointestinal (GI) cancers ectopically express multiple splice variants of the cholecystokinin-2 (CCK2)/gastrin receptor; however, their relative contributions to the cancer phenotype are unknown. The aim of this study was to compare the effects of CCK2 receptor (CCK2R) and CCK2i4svR expression on cell growth both in vitro and in vivo using a human epithelial cell model, HEK239. In vitro, receptor variant expression did not affect cell proliferation either in the absence or presence of agonist. However, in vivo, the expression of CCK2i4svR, but not CCK2R, increases HEK293 tumor growth in a constitutive, Src-dependent manner. Enhanced tumorigenicity of CCK2i4svR is associated with an Src-dependent increase in the transcription factor, hypoxia-inducible factor-1α, its downstream target, vascular endothelial growth factor and tumor micro-vessel density, suggesting that CCK2i4svR may contribute to the growth and spread of GI cancers through agonist-independent mechanisms that enhance tumor angiogenesis.

KW - Gastrin receptor

KW - Gastrointestinal cancer

KW - Src kinase

UR - http://www.scopus.com/inward/record.url?scp=33847063200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847063200&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1209862

DO - 10.1038/sj.onc.1209862

M3 - Article

C2 - 16909104

AN - SCOPUS:33847063200

VL - 26

SP - 1013

EP - 1019

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 7

ER -